v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities        
Net loss $ (2,716,000) $ (2,385,000) $ (9,230,000) $ (10,281,000)
Non-cash interest expense 1,230,000 1,081,000 4,424,000 4,283,000
Gain on change in fair value of related party convertible debt 61,000 (4,000) 311,000 22,000
Loss on disposition of property and equipment, net 2,000 2,000
Stock-based compensation expenses 5,000 5,000 21,000 33,000
Adjustments to reconcile net loss to net cash used in operating activities:        
Non-cash interest expense 1,230,000 1,081,000 4,424,000 4,283,000
Gain on change in fair value of related party convertible debt 61,000 (4,000) 311,000 22,000
Loss on disposition of property and equipment, net 2,000 2,000
Stock-based compensation expenses 5,000 5,000 21,000 33,000
Changes in assets and liabilities:        
Other receivables 20,000 45,000 (45,000)
Prepaid expenses and other current assets (18,000) (61,000) 77,000 (64,000)
Other non-current assets 1,000 2,000 (25,000) (1,000)
Accounts payable and accrued expenses 764,000 316,000 645,000 533,000
Accrued liabilities 136,000 282,000 1,664,000 1,118,000
Net cash used in operating activities (537,000) (742,000) (2,066,000) (4,402,000)
Cash flows from investing activities        
Property and equipment, net     (2,000)
Net cash provided by investing activities     (2,000)
Cash flows from financing activities        
Proceeds from issuance of senior notes 750,000 675,000 3,210,000 3,235,000
Proceeds from issuance of convertible loan 16,000 16,000 1,600,000
Proceeds from issuance of promissory notes     375,000
Repayment of senior notes     (150,000)
Repayment of related party promissory notes     (151,000)
Payment of deferred offering costs (385,000) (81,000) (961,000) (614,000)
Proceeds from issuance of common stock upon exercise of stock options     23,000
Net cash provided by financing activities 365,000 610,000 2,115,000 4,468,000
Net (decrease) in cash (172,000) (132,000) 49,000 64,000
Cash at the beginning of the period 191,000 142,000 142,000 78,000
Cash at the end of the period 19,000 10,000 191,000 142,000
Increase (decrease) in unpaid deferred offering costs (64,000) 212,000 269,000 72,000
Reconciliation of Cash and Restricted Cash:        
cash, end of the period 19,000   191,000 142,000
Supplemental disclosures of non-cash investing and financing information:        
Increase (decrease) in unpaid deferred offering costs (64,000) 212,000 269,000 72,000
NorthView Acquisition Corp        
Cash flows from operating activities        
Net loss (1,119,910) (820,277) (8,711,619) 1,161,910
Interest income on cash and marketable securities held in Trust Account (79,925) (116,664) (425,416) (2,248,538)
Change in fair value of warrant liabilities 348,085 504,723 539,531 (701,148)
Changes in fair value of convertible promissory note 225,330 (60,077) 7,165,953 (177,697)
Changes in fair value of securities purchase agreement 23,487    
Adjustments to reconcile net loss to net cash used in operating activities:        
Interest income on cash and marketable securities held in Trust Account (79,925) (116,664) (425,416) (2,248,538)
Change in fair value of warrant liabilities 348,085 504,723 539,531 (701,148)
Changes in fair value of convertible promissory note 225,330 (60,077) 7,165,953 (177,697)
Changes in fair value of securities purchase agreement 23,487    
Changes in assets and liabilities:        
Prepaid expenses and other current assets (27) (54,000) (7,416) 311,468
Accounts payable and accrued expenses 249,387 165,173 235,369 634
Prepaid income taxes 19,352 (30,492)
Prepaid Franchise taxes (19,400)    
Income tax payable 35,115 (49,061) (413,210)
Deferred tax liability (13,661) (13,661) (23,279)
Due to related party (8,820) 78,815 25,000
Net cash used in operating activities (362,441) (280,853) (1,296,812) (2,064,860)
Cash flows from investing activities        
Payment of extension fee into Trust Account (99,284) (125,021) (485,350) (438,360)
Cash withdrawn from Trust Account in connection with redemption 6,510,830 2,653,439 3,248,878 184,845,836
Reimbursement of franchise and income taxes from Trust Account 78,813 28,484 204,459 1,192,438
Net cash provided by investing activities 6,490,359 2,556,902 2,967,987 185,599,914
Cash flows from financing activities        
Proceeds from issuance of convertible loan 378,185 797,981 1,121,815
Advance from Profusa 385,158 791,407
Redemption of common stock (6,510,830) (2,653,439) (3,248,878) (184,845,836)
Net cash provided by financing activities (6,125,672) (2,275,254) (1,659,490) (183,724,021)
Net (decrease) in cash 2,246 795 11,685 (188,967)
Cash at the beginning of the period 16,204 4,519 4,519 193,486
Cash at the end of the period 18,450 5,314 16,204 4,519
Income taxes paid, inclusive of interest and penalties     173,727 912,437
Excise tax payable attributable to redemption of common stock 65,108 10,884 16,838 1,864,106
Accretion of common stock to redemption value 155,999 205,732 768,980 2,137,638
Reclassification of common stock subject to redemption to common stock to be redeemed     1,565,078
Reconciliation of Cash and Restricted Cash:        
Restricted cash – beginning of the period  
Reconciliation of Cash and Restricted Cash:        
cash, end of the period 5,314 16,204  
Restricted cash – end of the period 18,450
Supplemental disclosures of non-cash investing and financing information:        
Income taxes paid, inclusive of interest and penalties     173,727 912,437
Excise tax payable attributable to redemption of common stock 65,108 10,884 16,838 1,864,106
Accretion of common stock to redemption value $ 155,999 $ 205,732 768,980 2,137,638
Reclassification of common stock subject to redemption to common stock to be redeemed     $ 1,565,078